There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 11 | 1303 | 22855 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
Annual Revenue,rose 37.12%, in the last year to ₹2,053.15 Cr. Its sector's average revenue growth for the last fiscal year was 12.13%.Annual Net Profit,rose 39.94% in the last year to ₹364 Cr. Its sector's average net profit growth for the last fiscal year was 1.9%.Quarterly Revenue,rose 119.15% YoY to ₹650.07 Cr. Its sector's average revenue growth YoY for the quarter was 16.26%.
Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs. The company provides solutions across the full range of the pharmaceutical industry’s chemistry requirements from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life-cycle as well as commercial launch. Its core competency lies in the application of strong process chemistry to manufacturing in a regulatory compliant environment.
Neuland has been at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs.
The intraday low for Neuland Laboratories Ltd on the NSE today was ₹19,431.00. The stock's 52-week low stands at ₹11,500.00, recorded on 23 Mar 2026. Today's low is 68.97% above the 52-week low, indicating the stock is trading well above its yearly lows.
For Q1 FY27, Neuland Laboratories Ltd reported: Revenue (Net Sales): ₹6415.77 Cr - Down -17.35% year-on-year from ₹7762.50 Cr in Q4 FY26. Net Income (PAT): ₹1473.62 Cr - Down -30.66% year-on-year from ₹2125.23 Cr in Q4 FY26.
The intraday high for Neuland Laboratories Ltd on the NSE today (07 Aug 2026) was ₹23,500.00. This compares to the 52-week high of ₹22,490.00 recorded on 06 Aug 2026. Today's high was 4.49% above the 52-week high.
Over the last 6 months, Neuland Laboratories Ltd has given a return of 55.10%. The stock was priced at ₹13,030.00 on 06 Feb 2026 and has Rise to ₹22,915.00 as of 07 Aug 2026, a change of ₹9,885.00 per share.
As of 07 Aug 2026, the share price of Neuland Laboratories Ltd is ₹22,915.00 on the NSE and ₹22,905.00 on the BSE. The stock opened at ₹21,611.00, touched a high of ₹23,500.00 and a low of ₹19,431.00 during today's session.
Neuland Laboratories Ltd has delivered a return of 24.63% over the last 3 months. The stock was trading at ₹17,285.00 on 07 May 2026 and is currently at ₹22,915.00 as of 07 Aug 2026, reflecting a Gain of ₹5,630.00 per share over this period.
Yes,Neuland Laboratories Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 75.00 per share between FY2022 and FY2026, with the most recent dividend of ₹34.00 per share for May 26, with an ex-dividend date of 24 Jul 2026. At the current market price of ₹22,915.00, the trailing dividend yield of Neuland Laboratories Ltd stands at 34.00%.
Neuland Laboratories Ltd has delivered a 1236.83% absolute return over the past 5 years, equivalent to a CAGR of 67.96% per annum. The stock was priced at ₹1,714.13 in Aug 2021 and has risen to ₹22,915.00 as of 07 Aug 2026. An investment of ₹1,00,000 in Neuland Laboratories Ltd five years ago would be worth ₹13,36,830.00 today.
The all-time high (ATH) for Neuland Laboratories Ltd was ₹21,543.00, recorded on 06 Aug 2026. At the current price of ₹22,915.00, the stock is trading -6.37% below its all-time high. The all-time low recorded was ₹60.61 on 21 Nov 2011.
Neuland Laboratories Ltd has delivered 67.90% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹22,490.00 on 06 Aug 2026 and a 52-week low of ₹11,500.00 on 23 Mar 2026. It is currently trading at ₹22,915.00 as of 07 Aug 2026.
